These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 30972915)

  • 1. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
    Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
    J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double Positive CD4
    Kochanowicz AM; Osuch S; Berak H; Kumorek A; Caraballo Cortés K
    Cells; 2023 May; 12(10):. PubMed ID: 37408280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Osuch S; Laskus T; Perlejewski K; Berak H; Bukowska-Ośko I; Pollak A; Zielenkiewicz M; Radkowski M; Caraballo Cortés K
    Front Immunol; 2022; 13():832206. PubMed ID: 35386708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
    Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
    Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic CD4
    Huang N; Zhou R; Chen H; Zhang S; Li J; Wei W; Sun J; Ren S; Li B; Deng H; Yang J; Ji F; Li Z
    Int J Immunopathol Pharmacol; 2021; 35():20587384211061051. PubMed ID: 34930041
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
    Kroy DC; Ciuffreda D; Cooperrider JH; Tomlinson M; Hauck GD; Aneja J; Berger C; Wolski D; Carrington M; Wherry EJ; Chung RT; Tanabe KK; Elias N; Freeman GJ; de Kruyff RH; Misdraji J; Kim AY; Lauer GM
    Gastroenterology; 2014 Feb; 146(2):550-61. PubMed ID: 24148617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.
    Ackermann C; Smits M; Woost R; Eberhard JM; Peine S; Kummer S; Marget M; Kuntzen T; Kwok WW; Lohse AW; Jacobs T; Boettler T; Schulze Zur Wiesch J
    Sci Rep; 2019 Jul; 9(1):10624. PubMed ID: 31337800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C.
    Sumida K; Shimoda S; Iwasaka S; Hisamoto S; Kawanaka H; Akahoshi T; Ikegami T; Shirabe K; Shimono N; Maehara Y; Selmi C; Gershwin ME; Akashi K
    Clin Exp Immunol; 2013 Oct; 174(1):172-8. PubMed ID: 23773130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
    Dong RQ; Zhou DF; Han R; Zhou JY; Zhao CY; Zhen Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):899-902. PubMed ID: 24636290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral PD-1
    Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
    Front Immunol; 2019; 10():1470. PubMed ID: 31316516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.
    Sheiko MA; Golden-Mason L; Giugliano S; Hurtado CW; Mack CL; Narkewicz MR; Rosen HR
    J Pediatr; 2016 Mar; 170():142-8.e1. PubMed ID: 26743497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms.
    Hu H; Zhao J; Yuan J; Zhang M
    BMC Cancer; 2023 Mar; 23(1):287. PubMed ID: 36991376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma.
    Mosayebian A; Koohini Z; Hossein-Nataj H; Abediankenari S; Abedi S; Asgarian-Omran H
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):517-525. PubMed ID: 30644695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
    McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
    J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.